medigraphic.com
ISSN 1025-0255 (Electronic)

2013, Number 6

<< Back Next >>

AMC 2013; 17 (6)

Comprehensive attention to partners of men with condyloma acuminatum and the early diagnosis of cervical cancer

Ferrá TTM, Ramírez DI

Language: Spanish
References: 29
Page: 689-701
PDF size: 176.84 Kb.


ABSTRACT

Background: human papillomavirus is the causal agent of condylomaacuminatum and of cervical cancer. Condyloma acuminatum is generally caused by a human papillomavirus of low oncogenic risk but is a significant indicator of infection caused by a highrisk virus. Men play an important role in the epidemiology of cervical cancer.
Objective: to relate the comprehensive attention to the female partners of men with condyloma acuminatum to the early diagnosis of cervical cancer.
Methods: a descriptiveobservational and crosssectional study was conducted. The universe was composed of all the female partners of men with condyloma acuminatum that assisted to the dermatology consultation at the Manuel Ascunce Domenech Teaching Hospital in Camagüey from October 1st, 2010 to December 31st, 2011. A dermatological and gynecological examination was made; 5% acetic acid was applied for the subclinical detection and an organic cervical smear was made. Seventyfive women underwent a colposcopy and a cervical biopsy was made to those that presented alterations in the organic cervical smear. The information obtained was processed through the statistical program SPSS10. The employed method was the descriptive statistics of distribution of absolute and relative frequencies. The results of the study were exposed in tables.
Conclusions: almost all the women presented an evident infection caused by the human papillomavirus. The clinical form predominated in around three quarters of the total, the tenth part presented a subclinical form and the twentyfirst part presented both. Of the organic cervical smears, the ninth part presented cervical intraepithelial neoplasia, almost the half were of high risk, which coincided with the histological study. The forth part of the colposcopies results were abnormal, being the leukoplakia and the acetowhite predominant. The necessity for conducting a comprehensive study of every female partner of a man with condyloma acuminatum was confirmed.


REFERENCES

  1. Hathaway JK. HPV: diagnosis, prevention, and treatment. Clin Obstet Gynecol. 2012 Sep;55(3):67180.

  2. Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012 Jun;5(6):2536.

  3. SánchezVargas L O, Díaz Hernández C, Martínez Martínez. A. Detection of Human Papilloma Virus (HPV) in oral mucosa of women with cervical lesions and their relation to oral sex practices. Infectious Agents and Cancer. 2010;5:25.

  4. Brotherton JM, Gertig DM. Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact. Expert Rev Anti Infect Ther. 2011 Aug;9(8):62739.

  5. Nelson EL, Stockdale CK. Vulvar and Vaginal HPV Disease. Obstet Gynecol Clin North Am. 2013 Jun;40(2):35976.

  6. Giraldi G, De Luca d'Alessandro E. The HPV infection in males: an update. Ann Ig. 2012 NovDec;24( 6):497506.

  7. Álvarez Ramírez R. Detección del Virus del Papiloma Humano en Hombres Mediante Citología de Raspado Uretral utilizando la Citología en Fase Líquida. GEOSALUD [Internet]. 2005 [citado 9 Nov 2005]: [aprox. 5 p.]. Disponible en: http://geosalud .com/VPH/index%20VPH.htm

  8. Lantero Abreu MI, Torres Peña R, Joanes Fiol J, Alonso Gómez ME, Abreu Daniel A, Lobio Cárdenas Z, et al. Infecciones de transmisión sexual. Pautas para su tratamiento. La Habana: MINSAP; 2004.

  9. Leval A, Herweijer E, ArnheimDahlstrom L, Walum H, Frans E, Sparen P, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis. 2012 Sep 15;206(6):8606.

  10. Jamshidi M, Shekari M, Nejatizadeh AA, Malekzadeh K, Baghershiroodi M, Davudian P, et al. The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts. Arch Gynecol Obstet. 2012 Nov;286(5):12617.

  11. Kresge KJ. Cervical cancer vaccines: introduction of vaccines that prevent cervical cancer and genital warts may foreshadow implementation and acceptability issues for a future AIDS vaccine. /AV/ Rep [Internet]. 2005 [citado 9 Mar 2008];9(5):[aprox. 9 p.]. Disponible en: http://www.aegis.org/pubs/IAVI/2005/IAVI051101EN. htm/

  12. Shin TH, Pankhong P, Yan J, Khan AS, Sardesai NY, Weiner DB. Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen. Hum Vaccin Immunother. 2012 Apr;8(4):4708.

  13. Brotherton JM, Gertig DM. Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact. Expert Rev Anti Infect Ther. 2011 Aug;9(8):62739.

  14. Martínez MartínezPinillo A, Díaz Ortega I, Carr Pérez A, Varona Sánchez JA, Borrego López JA, de la Torre AI. Análisis de los principales factores de riesgo relacionados con el cáncer cérvico uterino en mujeres menores de 30 años. Rev Cubana Obstet Ginecol [Internet]. 2010 EneMar [citado 9 Mar 2008];36(1):[aprox. 12]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_isoref&pid=S0138600X2010000100008& lng=es&tlng=es

  15. Cuba. Dirección Nacional de Estadísticas. Anuario estadístico de salud. La Habana: Ecimed; 2011.

  16. Ramírez Morera A, Fuentes Belgrave L, DíazPastén S. La citología masculina en manos de mujeres. Rev Mujer Salud [Internet]. 2007 [citado 9 Mar 2012];81(34):[ aprox. 12]. Disponible en: http://madreselvamadreselva. blogspot.com/.

  17. Aubin F, Pretet C, Mougin D. Infection a papillomavirus humains. Ann Dermatol Venereol. 2007;134(1):949.

  18. Szarewski A. HPV vaccination and cervical cancer. Curr Oncol Rep. 2012 Dec;14(6):55967.

  19. Bosze P. The first vaccine against cancer: the human papillomavirus vaccine. Orv Hetil. 2013 Apr;154(16):60318.

  20. JuárezAlbarrán AC, Juárez Gámez CA. Vacuna contra el virus del papilomahumano. Rev Mes Inst Mex Seg Soc. 2008;46(6):6317.

  21. Ferrá Torres TM, Amador Díaz ME. Algunos aspectos epidemiológicos de los condilomas acuminados. Estudio de 307 casos. Arch Med Camagüey [Internet]. 2008 [citado 12 Ene 2009];12(3):[aprox. 13 p.]. Disponible en: http://www.cmw.sld.cu/amc/v12n32/ 567.htm

  22. Ferrá Torres TM. Estrada Abreu DR, Bermejo Bencomo W. Cáncer cérvico uterino y verrugas anogenitales: su relación. Arch Med Camagüey [Internet]. 2008 [citado 12 Ene 2009];12(1):[aprox. 13 p.]. Disponible en: http://www.amc.sld.cu/amc/2008/v12n1

  23. Mercer L, Harry TC. Outcome of partner notification in patients diagnosed with genital warts attending a provincial clinic in East Anglia, England. Int J STD AIDS. 2012 Jul;23(7):5189.

  24. de Lima Rocha MG, Faria FL, Goncalves L, Souza Mdo C, Fernandes PA, Fernandes AP. Prevalence of DNAHPV in male sexual partners of HPVinfected women and concordance of viral types in infected couples. PLoS One. 2012;7(7):e40988.

  25. Jaberipour M, Momtahan M, Najib F, Amooei S, Saidifard F, Ghaderi A, et al. Detection of highrisk human papillomavirus types 16 and 18 but not 33 and 52 in external genital warts from Iranian females. Asian Pac J Cancer Prev. 2011;12(3):7714.

  26. Ball SL, Winder DM, Vaughan K, Hanna N, Levy J, Sterling JC, et al. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol. 2011 Aug;839.

  27. Ferrá Torres TM, Del Río Ysla MB, Carrazana Hernández GB. Relación de las Verrugas AnoGenitales con lesiones precursoras de cáncer cérvico uterino. MediCiego [Internet]. 2008 [citado 12 Ene 2009];14(1):[aprox. 13 p.]. Disponible en: http://bvs.sld.cu/rvistas/mciego/v14supl108

  28. Araujo E, Barroso S, Cendón A, Muñoz M, Ortunio M, Cardoso R, et al. Infección por virus del papiloma humano en mujeres: hallazgos paraclínicos. Rev Obstet Ginecol Venez. 2010;70(2):829.

  29. Sarduy Nápoles M. Correlación citohistológica en las neoplasias intraepiteliales cervicales y en la identificación del VPH en esas lesiones. Rev Cubana Obstet Ginecol. EneMar 2009;35(1):4567.




2020     |     www.medigraphic.com